NMT Medical Appoints Paul H. Kramer, MD, To Board Of Directors

NMT Medical, Inc. (NASDAQ: NMTI) announced today that it has appointed Paul H. Kramer, MD, 59, to its Board of Directors. With his appointment, NMT is increasing the number of seats on its Board to eight.

“We are honored to have such an esteemed cardiologist serve on NMT’s Board,” said James J. Mahoney, Jr., Chairman of NMT’s Board of Directors. “Dr. Kramer is a recognized leader in the diagnosis and treatment of structural heart disease and is intimately familiar with our product family. Through his extensive clinical trial experience and active involvement in the interventional cardiology community, Dr. Kramer brings a unique perspective to our Board regarding the potential role of percutaneous cardiovascular interventions to prevent stroke. We look forward to his contributions to the Board as we await the CLOSURE I trial results.”

NMT also announced that current Board member, Cheryl L. Clarkson, who has served as a director since 2001, has decided not to stand for re-election at NMT’s 2010 Annual Meeting of Shareholders. At that time, NMT will reduce the number of board seats back to seven.

“For the past nine years, Cheryl Clarkson has been a valuable asset and trusted advisor to NMT and the Board,” said Mahoney. “We thank Cheryl for her guidance and excellent judgment during a period of significant progress for NMT. On behalf of the Board and the entire NMT team, we wish her well in her future endeavors.”

NMT will hold its 2010 Annual Meeting of Shareholders on Tuesday, July 27 at 2 p.m. ET. The meeting will be held at NMT’s corporate headquarters at 27 Wormwood Street, Boston, MA 02110.

Paul H. Kramer, MD, currently serves as the Chairperson of the Department of Cardiology and Medical Director of the Cardiac Catheterization Laboratory at the Liberty Regional Heart and Vascular Center, Liberty Hospital, Liberty, Missouri. Dr. Kramer trained in Cardiovascular Medicine at the University of California, San Francisco.